MedTrace Logo

Magnetic Therapy in Migraine Prophylaxis

NCT00901862 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2009-05-14

No results posted yet for this study

Summary

Background: The therapy with pulsed electromagnetic fields (PEFs) has been used as a therapeutic modality for at least 40 years. However, their effect in the migraine prophylaxis is unclear.

Objectives: Evaluate the prophylactic effectiveness of the therapy with PEFs in the handling of migraines.

Methodology: Placebo-controlled, randomized, double-blind, crossed clinical study.

Conditions

Interventions

DEVICE

Pulsed magnetic fields (Quantum MH-2MR bracelet)

Pulsed magnetic fields

DEVICE

Sham pulsed magnetic fields (Quantum MH-2MR bracelet)

Hybrid circuits crucial for the generation of the electromagnetic field had been removed.

Sponsors & Collaborators

  • El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

    lead OTHER

Principal Investigators

  • DANIEL SAN JUAN ORTA, MD · Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-03-31
Completion
2008-04-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00901862 on ClinicalTrials.gov